Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1953 1
1954 1
1956 2
1957 4
1958 1
1959 1
1960 8
1961 1
1962 2
1963 1
1964 5
1965 5
1966 3
1967 5
1968 1
1969 3
1970 1
1972 4
1973 2
1974 3
1975 3
1976 2
1977 2
1978 1
1979 3
1981 2
1982 1
1983 2
1984 3
1985 6
1986 3
1987 5
1988 4
1989 4
1990 6
1991 7
1992 4
1993 7
1994 6
1995 2
1996 6
1997 5
1998 5
1999 11
2000 8
2001 12
2002 13
2003 10
2004 16
2005 13
2006 16
2007 7
2008 6
2009 5
2010 9
2011 4
2012 10
2013 7
2014 10
2015 8
2016 9
2017 10
2018 4
2019 4
2020 3
2021 17
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Obstructive Pulmonary Disease: Evaluation and Management.
Duffy SP, Criner GJ. Duffy SP, et al. Med Clin North Am. 2019 May;103(3):453-461. doi: 10.1016/j.mcna.2018.12.005. Epub 2019 Mar 14. Med Clin North Am. 2019. PMID: 30955513 Review.
Chronic obstructive pulmonary disease (COPD) is a leading cause of death nationally and worldwide. ...No pharmacologic therapy has been shown to improve survival in COPD. Pulmonology referral is recommended for patients with COPD with symptoms despite first-line inh
Chronic obstructive pulmonary disease (COPD) is a leading cause of death nationally and worldwide. ...No pharmacologic therapy
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, Fabbri LM. MacLeod M, et al. Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24. Respirology. 2021. PMID: 33893708 Free article. Review.
Domiciliary NIV in those patients who are persistently hypercapnic following discharge and pulmonary rehabilitation can have a positive impact. For long-term prevention, inhaled therapy is key. Dual bronchodilators reduce exacerbation frequency but in patients with continu …
Domiciliary NIV in those patients who are persistently hypercapnic following discharge and pulmonary rehabilitation can have a positive impa …
Diagnosis and Treatment of Hemoptysis.
Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ, Herráez Ortega I, Jiménez Merchán R. Cordovilla R, et al. Arch Bronconeumol. 2016 Jul;52(7):368-77. doi: 10.1016/j.arbres.2015.12.002. Epub 2016 Feb 9. Arch Bronconeumol. 2016. PMID: 26873518 Review. English, Spanish.
Hemoptysis is the expectoration of blood from the tracheobronchial tree. It is commonly caused by bronchiectasis, chronic bronchitis, and lung cancer. The expectorated blood usually originates from the bronchial arteries. ...The procedure can be performed rapidly at …
Hemoptysis is the expectoration of blood from the tracheobronchial tree. It is commonly caused by bronchiectasis, chronic bronchit
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.
Singh D, Lea S, Mathioudakis AG. Singh D, et al. Drugs. 2021 Nov;81(16):1821-1830. doi: 10.1007/s40265-021-01616-9. Epub 2021 Nov 3. Drugs. 2021. PMID: 34731461 Review.
The orally administered PDE4 inhibitor roflumilast reduces exacerbation rates in the subgroup of chronic obstructive pulmonary disease patients with a history of exacerbations and the presence of chronic bronchitis, but can cause PDE4 related adverse effects …
The orally administered PDE4 inhibitor roflumilast reduces exacerbation rates in the subgroup of chronic obstructive pulmonary diseas …
Telemedicine in the management of chronic obstructive pulmonary disease: A systematic review.
Vila M, Rosa Oliveira V, Agustí A. Vila M, et al. Med Clin (Barc). 2023 Apr 21;160(8):355-363. doi: 10.1016/j.medcli.2023.01.008. Epub 2023 Feb 16. Med Clin (Barc). 2023. PMID: 36801105 Review. English, Spanish.
Telemedicine is defined as the use of electronic technology for information and communication by healthcare professionals with patients (or care givers) aiming at providing and supporting healthcare to patients away from healthcare institutions. ...Results showed that, alt …
Telemedicine is defined as the use of electronic technology for information and communication by healthcare professionals with patients (or …
New bronchoscopic treatment modalities for patients with chronic bronchitis.
Hartman JE, Garner JL, Shah PL, Slebos DJ. Hartman JE, et al. Eur Respir Rev. 2021 Jan 19;30(159):200281. doi: 10.1183/16000617.0281-2020. Print 2021 Mar 31. Eur Respir Rev. 2021. PMID: 33472961 Free PMC article. Review.
Chronic bronchitis is a chronic, progressive disease that is difficult to treat. ...Evaluation of this treatment is at a more advanced stage and promising effects on exacerbation frequency have been shown. However, confirmation of the benefit in improvement i
Chronic bronchitis is a chronic, progressive disease that is difficult to treat. ...Evaluation of this treatment is at
The clinical and integrated management of COPD.
Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM. Bettoncelli G, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2014 May 12;31 Suppl 1:3-21. Sarcoidosis Vasc Diffuse Lung Dis. 2014. PMID: 24820963 Review.
COPD is a chronic pathological condition of the respiratory system characterized by persistent and partially reversible airflow obstruction, to which variably contribute remodeling of bronchi (chronic bronchitis), bronchioles (small airway disease) and lung p …
COPD is a chronic pathological condition of the respiratory system characterized by persistent and partially reversible airflow obstr …
Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021.
Yang J, Ren HT, Wang J, Dong AY, Chen YL, Hu DX, Wang H, Ji HM, Wen HN, Chen Y, Shi DY. Yang J, et al. Int J Infect Dis. 2023 May;130:136-143. doi: 10.1016/j.ijid.2023.02.023. Epub 2023 Mar 4. Int J Infect Dis. 2023. PMID: 36871785 Free article.
RESULTS: Of the 130 nocardiosis cases, 99 (76.2%) were established as pulmonary infection, of which the most common underlying disease was chronic lung disease (40.4%, 40/99), including bronchiectasis, chronic obstructive pulmonary disease, and chronic bro
RESULTS: Of the 130 nocardiosis cases, 99 (76.2%) were established as pulmonary infection, of which the most common underlying disease was …
Re-evaluation for systematic reviews of traditional Chinese medicine in the treatment of chronic bronchitis.
Deng Y, Xi L, Han S, Liang T, Huang H, Fan Y, Zheng Y, Lin J. Deng Y, et al. Medicine (Baltimore). 2023 Dec 8;102(49):e36472. doi: 10.1097/MD.0000000000036472. Medicine (Baltimore). 2023. PMID: 38065925 Free PMC article. Review.
BACKGROUND: Chronic bronchitis (CB) is a common clinical chronic respiratory disease, which has a high incidence in the middle aged and elderly population. ...In recent years, there are many systematic reviews on the use of TCM therapy in the treatment …
BACKGROUND: Chronic bronchitis (CB) is a common clinical chronic respiratory disease, which has a high incidence in the …
Phenotyping Before Starting Treatment in COPD?
Siafakas N, Corlateanu A, Fouka E. Siafakas N, et al. COPD. 2017 Jun;14(3):367-374. doi: 10.1080/15412555.2017.1303041. Epub 2017 Apr 7. COPD. 2017. PMID: 28388265 Review.
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and complex disease with great morbidity and mortality. ...This review will discuss phenotypes, endotypes, and subgroups such as the frequent exacerbator, the one with systemic inflammation, the fast decliner,
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and complex disease with great morbidity and mortality. ...This revie
359 results